All In Biotech

Drug Trial Radar · NCT00326053

Prevention of Asthma Relapse After Discharge From Emergency

A Comparison of Budesonide/Formoterol Turbuhaler® 160/4.5 µg 2 Inhalations BID Plus as Needed to Budesonide Turbuhaler® 320 µg 2 Inhalations BID Plus Terbutaline Turbuhaler® 0.4 mg as Needed for the Prevention of Asthma Relapse

Last checked: Nov 20, 2026Latest source record: Jan 24, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

600

Planned (sponsor's estimate)

Start

May 2006

Primary completion

Not stated

Study completion May 2007

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
May 16, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to compare the Symbicort® Turbuhaler® to both Pulmicort® Turbuhaler® and Bricanyl® Turbuhaler® for the treatment of asthma after discharge from the emergency room

Conditions

  • Asthma

Interventions

  • Budesonide/formoterolDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first asthma relapse

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Calgary, Alberta, Canada

  • Research Site

    Edmonton, Alberta, Canada

  • Research Site

    Lethbridge, Alberta, Canada

  • Research Site

    St. Albert, Alberta, Canada

  • Research Site

    Nanaimo, British Columbia, Canada

  • Research Site

    Vancouver, British Columbia, Canada

  • Research Site

    Halifax, Nova Scotia, Canada

  • Research Site

    Truro, Nova Scotia, Canada

  • Research Site

    Hamilton, Ontario, Canada

  • Research Site

    Kingston, Ontario, Canada

  • Research Site

    Niagara Falls, Ontario, Canada

  • Research Site

    Ottawa, Ontario, Canada

  • Research Site

    Thunder Bay, Ontario, Canada

  • Research Site

    Toronto, Ontario, Canada

  • Research Site

    Charlottetown, Prince Edward Island, Canada

  • Research Site

    La Malbaie, Quebec, Canada

  • Research Site

    Montreal, Quebec, Canada

  • Research Site

    Québec, Quebec, Canada

  • Research Site

    Ste-Foy, Quebec, Canada

  • Research Site

    Saskatoon, Saskatchewan, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.